This contract involves the ongoing supply of medications as outlined in Appendix 1 of the Purchase Agreement – Price Offer. The supplies must include the pharmaceutical product Denosumab (M05BX04) in accordance with the tender conditions.
Contract awarded. Originally published 1 years ago.
No single supplier dominates the field.
In healthcare medical, RHEUMATOLOGY INSTITUTE has awarded 4 contracts to 4 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves the ongoing supply of specific medications as outlined in Appendix 1 of the Purchase Agreement – Price Offer. The required medications include methotrexate (L04AX03), leflunomide (L04AA13), and hydroxychloroquine (P01BA02). Suppliers must adhere to the procurement conditions a
This contract involves the ongoing supply of the medication Certolizumab (L04AB05) as detailed in Appendix 1 of the Purchase Agreement – Price Offer. Suppliers are expected to deliver the medication in accordance with the specified procurement conditions.
This contract involves the ongoing supply of the medication Etanercept (L04AB01) as detailed in Appendix 1 of the Purchase Agreement – Price Offer. Suppliers are expected to deliver these pharmaceutical products in accordance with the specified procurement conditions.
This contract involves the ongoing supply of the medication Belimumab (L04AA26) as detailed in Appendix 1 of the Purchase Agreement – Price Offer. Suppliers are expected to deliver the medication in accordance with the specified procurement conditions.
A three-year funded fellowship helping healthcare professionals with PhDs return to clinical research after extended career breaks.
BSMHFT intends to award the bereavement counselling service contract to the current provider following Committee approval on 3 March 2025.
Mental health crisis café and counselling service contract award under the Provider Selection Regime with a standstill period ending 26 March 2025.
Healthcare providers are invited to engage with the Authority to help shape upcoming PSR Framework Agreements for healthcare services.
